54
edits
Changes
PHAC Conflict of Interest Toolkit for Guideline Development (view source)
Revision as of 10:03, 15 June 2023
, 10:03, 15 June 2023no edit summary
PHAC, through its Guidance Innovation Hub has developed a compendium of tools, listed on this page, that can be used by national guideline development groups to help improve their practices related to the management of COI, including adherence to the GIN principles.
PHAC, through its Guidance Innovation Hub has developed a compendium of tools, listed on this page, that can be used by national guideline development groups to help improve their practices related to the management of COI, including adherence to the GIN principles.
== PHAC Disclosure of Interests Form and COI Assessment Tool ==
* [[Media:PHAC DOI form 11Sept2020 v9.0.docx|PHAC Dislosure of Interest Form (last updated Sept 11, 2020)]]
* [[Media:PHAC COI Tool 16Apr2021.xlsx|PHAC COI Assessment Tool (last updated April 16, 2021)]]
== Implementing the Guidelines International Network (GIN) Principles ==
Following the BBE, PHAC's Guidance Innovation Hub, along with BBE organizers and participants, developed practical guidance and tools for implementing the GIN principles, based on a scan of international best practices, informal interviews with guideline developers, and the experiences of the authors. This includes a checklist to aid journals seeking to implement the GIN principles on COI for authors, or guideline developers assessing or updating their policies to align with the GIN principles.
The article is published in CMAJ and is available in [https://www.cmaj.ca/content/193/2/E49 English] and [https://www.cmaj.ca/content/193/9/E324 French].
=== Examples of disclosure of interest forms: ===
== Additional resources from the international guideline community ==
=== Examples of disclosure of interest forms ===
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i12 American Thoracic Society disclosure of interests form]
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i12 American Thoracic Society disclosure of interests form]
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-coi-guidelines-form.docx CADTH pan-Canadian Oncology Drug Review disclosure of interest form for panel members]
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-coi-guidelines-form.docx CADTH pan-Canadian Oncology Drug Review disclosure of interest form for panel members]
=== Examples of scales for assessing the significance of COI ===
=== Examples of scales for assessing the significance of COI ===
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i13 American Thoracic Society method for evaluating significance of COI]
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i13 American Thoracic Society method for evaluating significance of COI]
* [https://www.who.int/publications/guidelines/handbook_2nd_ed.pdf World Health Organization criteria for assessing the severity of a conflict of interest] (see p. 78)
* [https://www.who.int/publications/guidelines/handbook_2nd_ed.pdf World Health Organization criteria for assessing the severity of a conflict of interest] (see p. 78)